North American IBD Therapeutics Market Size, Growth, Industry Trends, Market Share and Forecast 2019-2025

The North American IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.8% during the forecast period. Rising prevalence and incidence of IBD across the region is the major driving factor for the market. Moreover, an increasing number of cigarette-smokers in the US and significant funding in the IBD field in Canada is further estimated to boost the market growth of the region. Furthermore, well-developed healthcare expenditure coupled with increased per capita healthcare expenditure across the region will support the market growth over the forecast period.

Request a Free Sample of our Report on North American IBD therapeutics Market: https://www.omrglobal.com/request-sample/north-american-ibd-inflammatory-bowel-disease-therapeutics-market

Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per Crohn's and Colitis Canada (CCC), in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease, 120,000 with ulcerative colitis, and 15,000 with IBD type unclassified (IBD-U). CCC further estimates that seven out of every 1,000 Canadians have IBD. Moreover, by 2030, the number of people living with IBD is expected to rise to over 400,000, or nearly 1% of the population.

North American IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis.

For Crohn's and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

The companies which are contributing to the growth of the North American IBD therapeutics market include Abbott Laboratories, AbbVie Inc., Celgene Corp., Eli Lilly and Co., Johnson & Johnson Services Inc., Laboratory Corporation of America Holdings, Pfizer Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

A Full Report of North American IBD therapeutics Market is Available at https://www.omrglobal.com/industry-reports/north-american-ibd-inflammatory-bowel-disease-therapeutics-market

North American IBD THERAPEUTICS Market by Disease Type
o Ulcerative Colitis
o Crohn's Disease

North American IBD THERAPEUTICS Market by Treatment Type
o Surgery
o Anti- Inflammatory Drug Administration
o Steroids
o Immunosuppressant
o Biological Drugs
o Amino salicylates
o Others

Regional Analysis
o United States
o Canada

Company Profiles
o Abbott Laboratories
o AbbVie Inc.
o Boehringer Ingelheim International GmbH
o Celgene Corp.
o Eli Lilly and Co.
o Johnson & Johnson Services Inc.
o Laboratory Corporation of America Holdings
o Pfizer Inc.
o Sanofi S.A.
o Takeda pharmaceutical Co., Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-ibd-inflammatory-bowel-disease-therapeutics-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.